DFS tended to be better with S-@ ( median @ ( @ per cent c.i. @ to @ ) months versus @ ( @ to @ ) months in the gemcitabine group ; P = @ ) , with a similar pattern for overall survival : @ ( @ per cent c.i. @ to @ ) and @ ( @ to @ ) months respectively ( P = @ ) .